Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma - Concepedia

Concepedia

Publication | Open Access

Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma

DOI Full Paper Access

142

Citations

27

References

2011

Year

Joseph M. Parker, Chad K. Oh, Craig LaForce, S. David Miller, David S. Pearlman, Chenxiong Le, Gabriel J. Robbie, Wendy I. White, Barbara White, Néstor A. Molfino

BMC Pulmonary Medicine

References

	Year	Citations

Page 1